Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
Baltimore, Maryland, United States
Infectious disease physician in Baltimore, Maryland
1717 E Monument St, Baltimore, MD 21287
About Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
During the past decade, Johns Hopkins Hospital : The John G. Bartlett Specialty Practice conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Hospital : The John G. Bartlett Specialty Practice"
#1 collaborator was "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
According to Clinical.Site data, the most researched conditions in "Johns Hopkins Hospital : The John G. Bartlett Specialty Practice" are
"HCV Coinfection" (1 trials), "HIV" (1 trials), "Hepatitis C Virus Infection, Response to Therapy of" (1 trials), "Human Immunodeficiency Virus" (1 trials) and "Liver Disease" (1 trials). Many other conditions were trialed in "Johns Hopkins Hospital : The John G. Bartlett Specialty Practice" in a lesser frequency.
Clinical Trials Intervention Types at Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
Most popular intervention types in "Johns Hopkins Hospital : The John G. Bartlett Specialty Practice" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Sofosbuvir/Velpatasvir (SOF/VEL)" (1 trials), "Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]" (1 trials), "Usual Care" (1 trials), "Usual care plus incentives" (1 trials) and "Usual care plus peer-mentors" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
The vast majority of trials in "Johns Hopkins Hospital : The John G. Bartlett Specialty Practice" are
2 trials for "All" genders.
Clinical Trials Status at Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
Currently, there are NaN active trials in "Johns Hopkins Hospital : The John G. Bartlett Specialty Practice".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Johns Hopkins Hospital : The John G. Bartlett Specialty Practice,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Johns Hopkins Hospital : The John G. Bartlett Specialty Practice, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".